July 2, 2025: Mounjaro Patients in the United Kingdom Are Reporting Severe Pancreas Issues Mounjaro patients are experiencing severe pancreatitis (inflammation of the pancreas) and have had to be hospitalized
Water, stabilizer polydextrose, acidity regulator citric acid, L-carnitine, taurine, black carrot concentrate, white emulsion (stabilisers E 1450 and E 445), preservatives (potassium sorbate, sodium benzoate), antioxidant ascorbic acid, sweeteners (acesulfame K, sucralose), caffeine, flavouring
Axios , Insurers push back on GLP-1 coverage (Feb 2025) ( [65] )
It's important to discuss these with your healthcare provider to determine if Tirzepatide Compound therapy is right for you